Illumina, Chinese firm forge molecular Dx collaboration

04/22/2013 | GenomeWeb Daily News (free registration)

Illumina has entered a molecular diagnostics partnership with Kindstar Global, a provider of testing services in China. The deal calls for the companies to launch molecular diagnostic assays that use Illumina's TruSight sets for next-generation sequencing, NuPCR reagents for qPCR and the Infinium Dx CytoSNP-12 BeadChip test at Kindstar's laboratories.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY